Unravelling the Potential Mortality Benefits of Mass Drug Administration With Azithromycin in Niger

JAMA Netw Open. 2023 Dec 1;6(12):e2346811. doi: 10.1001/jamanetworkopen.2023.46811.

Author

Zulfiqar A Bhutta^{1

2}

Affiliations

¹ SickKids Centre for Global Child Health, Research Institute, The Hospital for Sick Children, SickKids Peter Gilgan Centre for Research and Learning, Toronto, Canada.
² Center of Excellence in Women and Child Health & Institute for Global Health & Development, The Aga Khan University South-Central Asia, East Africa & United Kingdom, Karachi, Pakistan.

PMID: 38100114
DOI: 10.1001/jamanetworkopen.2023.46811

No abstract available

Publication types

Comment

MeSH terms

Azithromycin* / therapeutic use
Humans
Mass Drug Administration*
Niger / epidemiology

Substances

Azithromycin